These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9258117)

  • 1. The significance of Ras guanine nucleotide exchange factor, son of sevenless protein, in renal cell carcinoma cell lines.
    Shinohara N; Ogiso Y; Tanaka M; Sazawa A; Harabayashi T; Koyanagi T
    J Urol; 1997 Sep; 158(3 Pt 1):908-11. PubMed ID: 9258117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.
    Watanabe T; Shinohara N; Moriya K; Sazawa A; Kobayashi Y; Ogiso Y; Takiguchi M; Yasuda J; Koyanagi T; Kuzumaki N; Hashimoto A
    IUBMB Life; 2000 Apr; 49(4):317-20. PubMed ID: 10995035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rce1 expression in renal cell carcinoma and its regulatory effect on 786-O cell apoptosis through endoplasmic reticulum stress.
    Li J; Wang D; Liu J; Qin Y; Huang L; Zeng Q; Xiao M; Hu J; Yang Q; He J; Mai L; Li Y; Liu W
    Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):254-261. PubMed ID: 28159979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y].
    Yokoyama T
    Hokkaido Igaku Zasshi; 1995 May; 70(3):459-71. PubMed ID: 7590597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.
    Chardin P; Camonis JH; Gale NW; van Aelst L; Schlessinger J; Wigler MH; Bar-Sagi D
    Science; 1993 May; 260(5112):1338-43. PubMed ID: 8493579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the regulation of glycolipid sulfotransferase activity in human renal cancer cells].
    Yabunaka N
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):289-300. PubMed ID: 7774881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y.
    Shichinohe T; Senmaru N; Furuuchi K; Ogiso Y; Ishikura H; Yoshiki T; Takahashi T; Kato H; Kuzumaki N
    J Surg Res; 1996 Dec; 66(2):125-30. PubMed ID: 9024823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of KRAS and BRAF mutation in renal cell carcinoma.
    Gattenlöhner S; Etschmann B; Riedmiller H; Müller-Hermelink HK
    Eur Urol; 2009 Jun; 55(6):1490-1. PubMed ID: 19282104
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitogenic activation of the Ras guanine nucleotide exchange factor in NIH 3T3 cells involves protein tyrosine phosphorylation.
    Li BQ; Subleski M; Shalloway D; Kung HF; Kamata T
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8504-8. PubMed ID: 8104337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Ras mutant, N116Y.
    Senmaru N; Shichinohe T; Takeuchi M; Miyamoto M; Sazawa A; Ogiso Y; Takahashi T; Okushiba S; Takimoto M; Kato H; Kuzumaki N
    Int J Cancer; 1998 Oct; 78(3):366-71. PubMed ID: 9766573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless.
    Erwin RA; Kirken RA; Malabarba MG; Farrar WL; Rui H
    Endocrinology; 1995 Aug; 136(8):3512-8. PubMed ID: 7628388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development.
    Wang DZ; Hammond VE; Abud HE; Bertoncello I; McAvoy JW; Bowtell DD
    Genes Dev; 1997 Feb; 11(3):309-20. PubMed ID: 9030684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiam1 mutations in human renal-cell carcinomas.
    Engers R; Zwaka TP; Gohr L; Weber A; Gerharz CD; Gabbert HE
    Int J Cancer; 2000 Nov; 88(3):369-76. PubMed ID: 11054665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor and isoproterenol stimulation of the Ras-guanine nucleotide exchange factor in proliferating rat parotid gland acinar cells.
    Wang PL; Nakagawa Y; Humphreys-Beher MG
    Biochem Biophys Res Commun; 1993 Apr; 192(2):860-6. PubMed ID: 8484791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo functional analysis of the Ras exchange factor son of sevenless.
    Karlovich CA; Bonfini L; McCollam L; Rogge RD; Daga A; Czech MP; Banerjee U
    Science; 1995 Apr; 268(5210):576-9. PubMed ID: 7725106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Sos activity by intramolecular interactions.
    Corbalan-Garcia S; Margarit SM; Galron D; Yang SS; Bar-Sagi D
    Mol Cell Biol; 1998 Feb; 18(2):880-6. PubMed ID: 9447984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
    Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
    J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor gene analysis in renal cell carcinoma.
    Gomella LG; Anglard P; Sargent ER; Robertson CN; Kasid A; Linehan WM
    J Urol; 1990 Jan; 143(1):191-3. PubMed ID: 2294252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of various human tumor cell lines by a dominant negative H-ras mutant.
    Ogiso Y; Sakai N; Watari H; Yokoyama T; Kuzumaki N
    Gene Ther; 1994 Nov; 1(6):403-7. PubMed ID: 7584106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.